메뉴 건너뛰기




Volumn 17, Issue 1, 2012, Pages

Cost estimating for turnarounds

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84865225584     PISSN: 1362363X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (7)

References (7)
  • 1
    • 84870568214 scopus 로고    scopus 로고
    • http://www.api.org/aboutoilgas/ sectors/refining/refinery-turnaround. cfm.
  • 2
    • 84870557924 scopus 로고    scopus 로고
    • http://ap-networks.com/latest-news/ tinc-europe-2011-summary.html.
  • 3
    • 84870494684 scopus 로고    scopus 로고
    • note
    • We are very aware of the fact that in recent years the preference within project cost estimating circles is not to talk of a typical ±10% or ±30% estimate, but rather to talk of "classes" of estimates. This is because of the need to recognise that for the same level of scope definition, two projects could have different levels of estimate accuracy because of the inherent risks in their characteristics. For example, a new technology project probably carries more risk than a similarsized project expanding an existing plant. However, the turnaround world has not yet reached that level of sophistication. Hence, for the survey, we used terms that are readily recognised, such as ±10% estimate.
  • 4
    • 42149106800 scopus 로고    scopus 로고
    • Stage gated approval processes - A practical way to develop and filter capital investment ideas
    • March/April
    • Lawrence G R, Stage gated approval processes - a practical way to develop and filter capital investment ideas, Pharmaceutical Engineering, vol 20, No 2, March/April 2008.
    • (2008) Pharmaceutical Engineering , vol.20 , Issue.2
    • Lawrence, G.R.1
  • 6
    • 84861535364 scopus 로고    scopus 로고
    • The use and misuse of contingency - Or why cutting contingency makes projects more expensive, not less
    • Sept/Oct
    • Lawrence G R, The use and misuse of contingency - or why cutting contingency makes projects more expensive, not less. Pharmaceutical Engineering, vol 27, No 5, Sept/Oct 2007.
    • (2007) Pharmaceutical Engineering , vol.27 , Issue.5
    • Lawrence, G.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.